Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life

Clinical Endocrinology

Volumn 73, Issue 4, 2010, Pages 546-550

  Vaiani, Elisa ^a   Herzovich, Viviana ^a   Chaler, Eduardo ^a   Chertkoff, Lilien ^a   Rivarola, Marco A ^a   Torrado, Maria ^a   Belgorosky, Alicia ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFANT; LIOTHYRONINE BLOOD LEVEL; MALE; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROID DISEASE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFANT; INFANT, NEWBORN; MALE; PRADER-WILLI SYNDROME; THYROID GLAND; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; THYROXINE;

EID: 77957050582     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03840.x     Document Type: Article

References (29)

1. Cassidy, S.B. (1997) Prader Willy syndrome. Journal Medical Genetics, 34, 917 923.
2. Torrado, M., Araoz, V., Baialardo, E. et al. (2007) Clinical-etiologic correlation in children with Prader-Willi syndrome (PWS): an interdisciplinary study. American Journal of Medical Genetics part A, 143, 460 468.
3. Gunay-Aygun, M., Schwartz, S., Heeger, S. et al. (2001) The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics, 108, E92.
4. Tauber, M., Barbeau, C., Jouret, B. et al. (2000) Auxological and endocrine evolution of 28 children with Prader Willi Syndrome: effect of GH therapy in 14 children. Hormone Research, 53, 279 287.
5. Burman, P., Ritzén, E.M. Lindgren, A.C. (2001) Endocrine dysfunction in Prader Willi Syndrome. A review with special reference to GH. Endocrine Reviews, 22, 787 799.
6. Eiholzer, U., l'Allemand, D., Rousson, V. et al. (2006) Hypothalamic and gonadal components of hypogonadism in boys with Prader Willi Syndrome. The Journal of Clinical Endocrinology & Metabolism, 91, 892 898.
7. Miller, J.L., Couch, J.A., Schmalfuss, I. et al. (2007) Intracranial abnormalities detected by three-dimensional magnetic resonance imaging in Prader Willi Syndrome. American Journal Medical Genetics part A, 143, 476 483.
8. Eiholzer, U., Gisin, R., Weinmann, C. et al. (1998) Treatment with human growth hormone in patients with Prader-Labhart-Willi syndrome reduces body fat and increases muscle mass and physical performance. European Journal of Pediatrics, 157, 368 377.
9. International Federation of Clinical Chemistry Scientific Committee, Clinical Section Expert Panel on Theory of reference Values and International Committee for Standardization in Haematology (1987) Part 5. Statistical treatment on theory pf reference value: determinations of reference limits. Jornal of Clinical Chemistry and Clinical Biochemistry, 25, 645 656.
10. Rose, S.R. American Academy of Pediatrics, Section on Endocrinology and Committee on Genetics Brown, R.S. et al. 2006) Update of newborn screening and therapy for congenital hypothyroidism. Pediatrics, 117, 2290 2303.
11. Lejarraga, H., del Pino, M., Fano, V. et al. (2009) Growth references for weight and height for Argentinian girls and boys from birth to maturity: incorporation of data from the World Health Organization from birth to two years and calculation of new percentiles and LMS values. Archivos Argentinos de Pediatria, 107, 126 133.
12. Goldstone, A.P. (2004) Prader-Willi syndrome: advances in genetics, pathophysiology and treatment. Trends in Endocrinology and Metabolism, 15, 12 20.
13. Butler, M.G., Theodoro, M. Skouse, J.D. (2007) Thyroid function studies in Prader Willi syndrome. American Journal of Medical Genetics part A, 143, 488 492.
14. Bray, G.A., Dahms, W.T., Swerdloff, R.S. et al. (1983) The Prader- Willi syndrome: a study of 40 patients and review of the literature. Medicine (Baltimore), 62, 59 80.
15. Sher, C., Bistritzer, T., Reisler, G. et al. (2002) Congenital hypothyroidism with Prader-Willi syndrome. Journal of Pediatrics Endocrinology and Metabolism, 15, 105 107.
16. Insoft, R.M., Hurvitz, J., Estrella, E. et al. (1999) Prader-Willi syndrome associated with fetal goiter: a case report. American Journal Perinatology, 16, 29 31.
17. Festen, D.A., Visser, T.J., Otten, B.J. et al. (2007) Thyroid hormone levels in children with PWS before and during growth hormone treatment. Clinical Endocrinology (Oxf), 67, 449 456.
18. Lee, S., Walker, C.L., Karten, B. et al. (2005) Essential role for the Prader-Willi syndrome protein necdin in axonal outgrowth. Human Molecular Genetics, 14, 627 637.
19. Bacheré, N., Diene, G., Delagnes, V. et al. (2008) Early diagnosis and multidisciplinary care reduce the hospitalization time and duration of tube feeding and prevent early obesity in PWS infants. Hormone Research, 69, 45 52.
20. Carrel, A.L., Moerchen, V., Myers, S.E. et al. (2004) Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. Journal of Pediatrics, 145, 744 749.
21. Festen, D.A., Wevers, M., Lindgren, A.C. et al. (2008) Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. The Clinical Endocrinology (Oxf), 68, 919 925.
22. Jørgensen, J.O., Pedersen, S.A., Laurberg, P. et al. (1989) Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism. The Journal of Clinical Endocrinologyand Metabolism, 69, 1127 1132.
23. Jørgensen, J.O., Møller, J., Skakkebaek, N.E. et al. (1992) Thyroid function during growth hormone therapy. Hormone Research, 38 (Suppl 1 63 67.
24. Jørgensen, J.O., Møller, J., Laursen, T. et al. (1994) Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clinical Endocrinology (Oxf), 41, 609 614.
25. Maia, A.L., Kim, B.W., Huang, S.A. et al. (2005) Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. The Journal of Clinical Investigation, 115, 2524 2533.
26. Cettour-Rose, P., Burger, A., Meier, C. et al. (2002) Central stimulatory effect of leptin on T3 production is mediated by brown adipose tissue type 2 deiodinase. American Journal of Physiology Endocrinology Metabolism, 283, E 980 E 987.
27. Haqq, A.M., Grambow, S.C., Muehlbauer, M. et al. (2008) Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clinical Endocrinology (Oxf), 69, 911 920.
28. Eiholzer, U., Blum, W.F. Molinari, L. (1999) Body fat determined by skinfold measurements is elevated despite underweight in infants with Prader-Labhart-Willi syndrome. Journal of Pediatrics, 134, 222 225.
29. Adler, S.M. Wartofsky, L. (2007) The nonthyroidal illness syndrome. Endocrinology and Metabolism Clinical North America, 36, 657 672.